1-[4-(Diphenylmethyl)piperazin-1-yl]-2,2-diphenylethan-1-one

Catalog No. :
ACFBHS226
CAS No. :
48230-15-5
Molecular Formula :
C31H30N2O
Molecular Weight :
446.59

IUPAC Name:1-(4-benzhydrylpiperazin-1-yl)-2,2-diphenylethan-1-one

1-[4-(Diphenylmethyl)piperazin-1-yl]-2,2-diphenylethan-1-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-[4-(Diphenylmethyl)piperazin-1-yl]-2,2-diphenylethan-1-one
IUPAC Name1-(4-benzhydrylpiperazin-1-yl)-2,2-diphenylethan-1-one
MDL No.MFCD01042101
Molecular FormulaC31H30N2O
Molecular Weight446.59
SMILESO=C(N1CCN(C(C2=CC=CC=C2)C3=CC=CC=C3)CC1)C(C4=CC=CC=C4)C5=CC=CC=C5
InChI KeyGNGAFWNGMQIIFB-UHFFFAOYSA-N
Synonym1-(4-(DIPHENYLMETHYL)PIPERAZINYL)-2,2-DIPHENYLETHAN-1-ONE;1-[4-(diphenylmethyl)piperazin-1-yl]-2,2-diphenylethan-1-one;Ethanone, 1-[4-(diphenylmethyl)-1-piperazinyl]-2,2-diphenyl-
CAS No.48230-15-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACFBHS226 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWUJC437 route compound structure diagram
    ACWUJC437117-34-0 In Stock
  2. Plus
  3. ACONZR821 route compound structure diagram
    ACONZR821841-77-0 In Stock
  4. Then
  5. ACFBHS226 route product structure diagram
    ACFBHS22648230-15-5
Inquiry

2. ACFBHS226 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACONZR821 route compound structure diagram
    ACONZR821841-77-0 In Stock
  4. Then
  5. ACFBHS226 route product structure diagram
    ACFBHS22648230-15-5
Inquiry

Comments (0)